It is also worth noting that rapid weight loss associated with GLP-1 receptor agonist therapy is linked to an increased risk of gallstone formation and gallbladder disease (cholecystitis), a class effect recognised in the SmPCs for semaglutide and tirzepatide
~ AlphaMD You're standing in your kitchen, staring at the open refrigerator, trying to remember what the hell you came in here for
Choosing Healthy Carbs
Raking in more than $16 billion, this drug, marketed as Ozempic (Novo Nordisk) and Wegovy (Novo Nordisk), became a household name and highly coveted commodity in the treatment of type 2 diabetes and for weight management, respectively
Providing insights into pricing, insurance, and cost-effective choices helps patients make informed decisions about their treatment and financial options
Most GLP-1 side effects are temporary and diminish as your body adapts